NCT05887245Active, not recruiting
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy
Znaczenie Kliniczne przywierającego tłuszczu okołonerkowego u pacjentów Poddawanych Resekcji Guza Nerki
Source: ClinicalTrials.gov · Last updated 27 Jun 2025
Brief summary (registry, in English)
The aim of this study is to gain a better understanding of the phenomenon of adherent perinephric fat (APF), which occurs in some patients undergoing partial nephrectomy (PN). This phenomenon, so-called "toxic fat", is a commonly recognized problem among urologists, but its significance has not yet been fully understood. The study aims to identify new clinical risk factors for APF occurrence and evaluate its impact on functional, perioperative, and oncological treatment outcomes. The study will be conducted on patients who are qualified for PN surgery. Prior to the surgical procedure, venous blood will be collected, which will be used for various measurements, such as blood morphology, kidney parameters, inflammation markers, liver function tests, glucose, and lipid profile. In addition, medical data will be collected concerning the patient's overall health, observed changes in the kidney, perioperative course, hospitalization, and histopathological characteristics of the tumor. After treatment, patients will be followed up for up to 60 months. The knowledge gained from this study can significantly assist in making decisions about surgical treatment and thus contribute to improving the treatment outcomes of patients with kidney tumors.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 18 May 2023
- Start date
- 17 Apr 2023
- Primary completion date
- 17 Apr 2025
- Lead sponsor
- Centre of Postgraduate Medical Education
- Diseases
- Kidney cancer
- NCT number
- NCT05887245
What you commit to
- Study type: Observational
- Planned participants: 200
- From 17 Apr 2023 to the primary completion date, 17 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with recurrent kidney cancer, or who have undergone other surgeries within the kidney
Other
- Patient does not give consent to participate in the study
- Lack of preoperative imaging available for assessment
- Missing medical documentation that prevents data analysis
Who the study is looking for
- Patients qualified for partial nephrectomy by open, laparoscopic, or robotic method
- Tumor stage cT1a-cT1b according to Tumour Node Metastasis classification
- Age ≥ 18 years
- Written consent to participate in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| European Health Centre, Second Department of Urology, Centre of Postgraduate Medical Education Coordinator of this site? Confirm its status | Otwock | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.